Home Newsfeeds Barclays Maintains Overweight on Immunogen, Raises Price Target to $9

Barclays Maintains Overweight on Immunogen, Raises Price Target to $9

Barclays analyst Peter Lawson maintains Immunogen (NASDAQ:IMGN) with a Overweight and raises the price target from $8 to $9.

byBenzinga Newsdesk

November 15, 2022

1 minute read

Barclays analyst Peter Lawson maintains Immunogen (NASDAQ:IMGN) with a Overweight and raises the price target from $8 to $9.

Silk Road Medical, Acadia Healthcare And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

By Lisa Levin

July 12, 6:40 AM

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

ACHC

Investor Fear Eases Ahead Of Fed’s Decision; Dow Notches Best Day Since June

By Lisa Levin

October 31, 2:16 AM

The CNN Money Fear and Greed index showed easing in the overall fear level, with the index moving to the "Fear" zone on Monday. U.S. stocks closed sharply higher on Monday, with the Dow Jones recording its best session since June 2 ahead of Federal Reserve’s interest rate decision and jobs report, due this week.

AMD

Healthcare Insurance Giant Cigna Mulls Offloading Medicare Advantage Business

By Vandana Singh

November 6, 2:17 PM

Cigna Corporation (NYSE: CI) is reportedly contemplating the sale of its Medicare Advantage business and working with an investment bank to explore options for a business that could be worth billio

Alibaba, Nio Rise Over 1% As Hong Kong Tech Stocks Cheer Wall Street Rebound: Cautious Investors Eye Key Fed Event

By Bhavik Nair

September 7, 10:35 PM

Major U.S.-listed Chinese tech and electric-vehicle stocks rose in Hong Kong on Thursday, with Alibaba and Nio adding over 1%, tracking an upbeat overnight finish on Wall Street.

BABA

Barclays Maintains Overweight on Immunogen, Raises Price Target to $9

Related Posts

Silk Road Medical, Acadia Healthcare And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Investor Fear Eases Ahead Of Fed’s Decision; Dow Notches Best Day Since June

Healthcare Insurance Giant Cigna Mulls Offloading Medicare Advantage Business

Alibaba, Nio Rise Over 1% As Hong Kong Tech Stocks Cheer Wall Street Rebound: Cautious Investors Eye Key Fed Event